(111) Registration Number |
018887467 |
(151) Date of the registration |
10-07-2023 |
(210) Serial number of the application |
018887467 |
(220) Date of filing of the application |
13-06-2023 |
(180) Expected expiration date of the registration/renewal |
13-06-2033 |
(731) Name and address of the applicant |
Ring Therapeutics, Inc. Ring Therapeutics, Inc. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 ESTADOS UNIDOS (DE AMÉRICA) |
(511) The International Classification of Goods and Services for the Purposes of the Registration of Marks (Nice Classification) and the list of goods and services classified according thereto |
5: Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases and infectious diseases; encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases and eye diseases and disorders; encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases. |
(541) Reproduction of the mark where the mark is represented in standard characters |
RING THERAPEUTICS |
(740) Name and address of the representative |
HGF BV |
(750) Address for correspondence |
HGF BV
Gedempt Hamerkanaal 147
1021 KP Amsterdam
PAÍSES BAJOS |